Arterial perfusion chemoembolization combined with iodine‑125 seeds for stage IIB osteosarcoma: A case report

Ran,Linhao; Li,Fan; Jiang,Li; Yang,Li; Liu,Ying

doi:10.3892/ol.2025.15093

Arterial perfusion chemoembolization combined with iodine‑125 seeds for stage IIB osteosarcoma: A case report

Authors:
- Linhao Ran
- Fan Li
- Li Jiang
- Li Yang
- Ying Liu
View Affiliations

Affiliations: Department of Nuclear Medicine, Banan Hospital of Chongqing Medical University, Chongqing 401320, P.R. China, Department of Ultrasound, Banan Hospital of Chongqing Medical University, Chongqing 401320, P.R. China, Department of Pathology, Banan Hospital of Chongqing Medical University, Chongqing 401320, P.R. China
Published online on: May 15, 2025 https://doi.org/10.3892/ol.2025.15093
Article Number: 347
Copyright: © Ran et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma is a highly malignant bone tumor that predominantly affects adolescents. Its aggressive nature, complex treatment options and poor prognosis render it a notable concern in oncology. With advancements in therapy for osteosarcoma, neoadjuvant chemotherapy in conjunction with limb‑salvage surgery has emerged as the preferred surgical strategy. However, the physical and emotional trauma associated with surgery, along with the adverse side effects of chemotherapy, can be unacceptable to some patients. In recent years, alternative local treatment modalities such as transarterial chemoembolization (TACE) and iodine‑125 seed implantation have garnered considerable attention. These techniques show potential in enhancing local tumor control while minimizing systemic toxicity. TACE involves obstructing the blood supply to the tumor while administering localized chemotherapy, resulting in tumor ischemia and necrosis, which is particularly effective for hypervascular tumors. Meanwhile, iodine‑125 seeds act as low‑energy radiation sources that can effectively target tumor cells while sparing the surrounding healthy tissue. The present study describes a case of osteosarcoma treated with a combination of TACE and iodine‑125 seed implantation. The patient, diagnosed with osteosarcoma of the left knee joint, declined surgical intervention. Consequently, a treatment plan involving TACE paired with iodine‑125 seed implantation was established. Post‑treatment follow‑up demonstrated marked pain relief, improved limb function and a notable reduction in tumor volume with decreased bone destruction visible on imaging. Over a follow‑up period of 6 years, there were no signs of disease recurrence or distant metastasis, and no notable chemotherapy‑related side effects were reported. The quality of life of the patient was markedly improved. The current case illustrates the antitumor efficacy and reduced toxicity of combining TACE with iodine‑125 seed implantation in the management of osteosarcoma.

View Figures

View References

1	Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, et al: Burden and centralised treatment in Europe of rare tumours: Results of RARECAREnet-a population-based study. Lancet Oncol. 18:1022–1039. 2017. View Article : Google Scholar : PubMed/NCBI
2	De Pinieux G, Karanian M, Le Loarer F, Le Guellec S, Chabaud S, Terrier P, Bouvier C, Batistella M, Neuville A, Robin YM, et al: Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One. 16:e02469582021. View Article : Google Scholar : PubMed/NCBI
3	Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, et al: Bone sarcomas: Esmoeuracan-genturis-ernpaedcan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 32:1520–1536. 2021. View Article : Google Scholar : PubMed/NCBI
4	Storey L, Fern LA, Martins A, Wells M, Bennister L, Gerrand C, Onasanya M, Whelan JS, Windsor R, Woodford J and Taylor RM: A critical review of the impact of sarcoma on psychosocial wellbeing. Sarcoma. 2019:97308672019. View Article : Google Scholar : PubMed/NCBI
5	Li F, Zhang DB, Ma Y, Song Y and Duan XL: Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis. Pak J Med Sci. 40:648–651. 2024. View Article : Google Scholar : PubMed/NCBI
6	Peng SH, Mbarak HS, Li YH, Ma C, Shang QL, Chen Z, Bian DJ and Xiao EH: Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer. Medicine. 100:e283122021. View Article : Google Scholar : PubMed/NCBI
7	Kou F, Gao S, Liu S, Wang X, Chen H, Zhu X, Guo J, Zhang X, Feng A and Liu B: Preliminary clinical efficacy of iodine-125 seed implantation for the treatment of advanced malignant lung tumors. J Cancer Res Ther. 15:1567–1573. 2019. View Article : Google Scholar : PubMed/NCBI
8	Chen Y, Jiang Y, Ji Z, Jiang P, Xu F, Zhang Y, Zhang P, Guo F, Li X, Sun H, et al: Dosimetry, efficacy, and safety of three-dimensional printing noncoplanar template-assisted and CT-guided 125I seed implantation for recurrent retroperitoneal lymphatic metastasis after external beam radiotherapy. Brachytherapy. 19:380–388. 2020. View Article : Google Scholar : PubMed/NCBI
9	He S, Renne A, Argandykov D, Convissar D and Lee J: Comparison of an emoji-based visual analog scale with a numeric rating scale for pain assessment. JAMA. 328:208–209. 2022. View Article : Google Scholar : PubMed/NCBI
10	Cates JMM: Comparison of the AJCC, MSTS, and Modified Spanier Systems for Clinical and Pathologic Staging of Osteosarcoma. Am J Surg Pathol. 41:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
11	Brierley JD and Wittekind C: TNM Classification of Malignant Tumours. 8 edition. John Wiley & Sons; Oxford: 2016
12	Jin Q, Xie X, Yao H, Wen L, Li H, Lv D, Zeng Z, Wang Y, Zou C, Yin J, Huang G, Wang B, et al: Clinical significance of the radiological relationship between the tumor and the main blood vessels in Enneking IIB osteosarcoma of the extremities. J Cancer. 11:3235–3245. 2020. View Article : Google Scholar : PubMed/NCBI
13	Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009. View Article : Google Scholar : PubMed/NCBI
14	Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, AlvegardAlvegard TA, Picci P, Capanna R, Bernini G, et al: Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 23:8845–8852. 2005. View Article : Google Scholar : PubMed/NCBI
15	Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, et al: Survival and prognosis with osteosarcoma: Outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 109:36–50. 2019. View Article : Google Scholar : PubMed/NCBI
16	Kallis M, Maloney C, Edelman M, Soffer S, Symons M and Steinberg B: Abstract PR13: Surgical excision of the primary tumor in osteosarcoma model results in enhanced metastatic growth by modulating the lung immune microenvironment. Cancer Res. 80 (Suppl 1):PR13. 2020. View Article : Google Scholar
17	Niculescu ȘA, Grecu AF, Gheonea C and Grecu DC: Limb salvage surgery in pediatric patients with osteosarcoma. Curr Health Sci J. 50:360–367. 2024.PubMed/NCBI
18	Gaspar N, Venkatramani R, Hecker-Nolting S, Melcon SG, Locatelli F, Bautista F, Longhi A, Lervat C, Entz-Werle N, Casanova M, et al: Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): A multicentre, open-label, multicohort, phase 1/2 study. Lancet Oncol. 22:1312–1321. 2021. View Article : Google Scholar : PubMed/NCBI
19	Liao L, Li X, Wei G, Lu Y, Wei S, Lin K and Zhang F: Efficacy of transcatheter arterial chemoembolization combined with radiotherapy for locally advanced hepatocellular carcinoma. Am J Transl Res. 16:6935–6945. 2024. View Article : Google Scholar : PubMed/NCBI
20	Zhao YW, Liu S, Qin H, Sun JB, Su M, Yu GJ, Zhou J, Gao F, Wang RY, Zhao T and Zhao GS: Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study. Front Oncol. 13:11109172023. View Article : Google Scholar : PubMed/NCBI
21	Di X, Zhang H, Liu X, Zhao J, Gao Z, Yu H, Su X, Liang Y and Wang J: A new technique for trans-perirectal iodine-125 seed implantation in prostatic cancer guided by CT and 3D printed template: Two case reports. Front Oncol. 12:10319702022. View Article : Google Scholar : PubMed/NCBI
22	Tang M, Lin X, Zhu L, Liu J, Ye X, Miu R and Hu J: The efficacy and safety of percutaneous CT-guided iodine-125 brachytherapy combined with standard chemotherapy and brachytherapy alone for lung malignant nodule: A retrospective comparative cohort study. J Thorac Dis. 16:573–580. 2024. View Article : Google Scholar : PubMed/NCBI
23	Sui A, Song H, Yu H, Zhang H, Hu Q, Lei Y, Zhang L and Wang J: Clinical application of iodine-125 seed brachytherapy combined with anti-PD-1 antibodies in the treatment of lung cancer. Clin Ther. 42:1612–1616. 2020. View Article : Google Scholar : PubMed/NCBI
24	Chen C, Wang W, Yu Z, Tian S, Li Y and Wang Y: Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy. Lung Cancer. 146:290–296. 2020. View Article : Google Scholar : PubMed/NCBI
25	Katagiri H, Sugiyama H, Takahashi M, Murata H, Wasa J, Hosaka S and Miyagi M: Osteosarcoma of the pelvis treated successfully with repetitive intra-arterial chemotherapy and radiation therapy: A report of a case with a 21-year follow-up. J Orthop Sci. 20:568–573. 2015. View Article : Google Scholar : PubMed/NCBI
26	Takaki H, Hirata Y, Ueshima E, Kodama H, Matsumoto S, Wada R, Suzuki H, Nakasho K and Yamakado K: Hepatic artery embolization enhances expression of programmed cell death 1 ligand 1 in an orthotopic rat hepatocellular carcinoma model: in vivo and in vitro experimentation. J Vasc Interv Radiol. 31:1475–1482.e2. 2020. View Article : Google Scholar : PubMed/NCBI
27	Chao Y, Wu CY, Kuo CY, Wang JP, Luo JC, Kao CH, Lee RC, Lee WP and Li CP: Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization. Hepatol Int. 7:883–892. 2013. View Article : Google Scholar : PubMed/NCBI